US · Healthcare

United Therapeutics Corporation (UTHR)

Drug Manufacturers - Specialty & Generic

United Therapeutics Corporation (UTHR) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for UTHR

P/E ratio

18.00

United Therapeutics Corporation (UTHR) — FAQ

What is UTHR's P/E ratio?

The price-to-earnings (P/E) ratio for United Therapeutics Corporation (UTHR) is 18.00 (data as of 2026-03-24).

Does United Therapeutics Corporation pay a dividend?

Dividend yield is not available in the current snapshot for United Therapeutics Corporation (UTHR). Check the MyAverix Finance app for the latest dividend data.

What sector is United Therapeutics Corporation in?

United Therapeutics Corporation (UTHR) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is UTHR listed on?

UTHR is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)